Challenges and strategies in anti-cancer nanomedicine development: An industry perspective ☆

Volume: 108, Pages: 25 - 38
Published: Jan 1, 2017
Abstract
Successfully translating anti-cancer nanomedicines from pre-clinical proof of concept to demonstration of therapeutic value in the clinic is challenging. Having made significant advances with drug delivery technologies, we must learn from other areas of oncology drug development, where patient stratification and target-driven design have improved patient outcomes. We should evolve our nanomedicine development strategies to build the patient and...
Paper Details
Title
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective ☆
Published Date
Jan 1, 2017
Volume
108
Pages
25 - 38
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.